Evento S-GE Fattori chiave di successo per fare affari in Giappone Apr 23, 2024 10:15–12:10 Zürich Switzerland
Événements S-GE Facteurs de succès clés pour faire des affaires au Japon Apr 23, 2024 10:15–12:10 Zürich Switzerland
Event S-GE Schlüssel zum Erfolg: Strategische Faktoren für Geschäftsaktivitäten in Japan Apr 23, 2024 10:15–12:10 Zürich Switzerland
Aktuell Oct 19, 2023 Forschende kehren Therapieresistenz bei Prostatakrebs um Forschende des Instituts für Onkologische Forschung (IOR) haben herausgefunden, wodurch Therapieresistenzen bei Prostatakrebs umgekehrt werden kö...
Actualités Dec 19, 2023 Les Grands Titres de Suisse occidentale (Octobre-Décembre 2023) De l’obtention des meilleurs classements en matière d’innovation mondiale à la réalisation d’avancées significatives dans les domaines de la sant...
News Oct 19, 2023 Researchers reverse prostate cancer therapy resistance Researchers at the Institute of Oncology Research (IOR) have discovered how to reverse prostate cancer therapy resistance. This advancement came ...
Actualités Oct 20, 2023 Lonza s’agrandit pour fabriquer le vaccin pneumococcique conjugué de Vaxcyte Lonza et la société américaine Vaxcyte, spécialisée dans l’innovation vaccinale de stade clinique, ont annoncé le renforcement de leur partenaria...
News May 24, 2023 Latest research shows 20% of European biotechs now headquartered in Switzerland Press release New research conducted by IQVIA and recently published in the 2023 Swiss Biotech Report shows that 20% of European biotech companies are now head...
Actualités Sep 29, 2023 Les Grands Titres de Suisse occidentale (Juillet-Septembre 2023) De l'élaboration de solutions éco-innovantes à des avancées pionnières dans les domaines de la technologie solaire, de la recherche sur le cancer...
News Dec 11, 2023 Cytiva’s strategic expansion in Western Switzerland’s Health Valley Cytiva, a global life sciences leader, has recently bolstered its operations in the Health Valley through a strategic merger with Pall Life Scien...
News Jun 21, 2022 Takeda to invest CHF 200 million in its Neuchâtel production site Japanese pharmaceutical group Takeda will be expanding its production site in Pierre-à-Bot and build a new aseptic filling line, an investment of...
Manual para investidores Nov 11, 2020 Manual para investidores O manual contém informações sobre as principais vantagens da Suíça como local de negócios, bem como sobre o ambiente atual de investimento, custo...
Guía para invertir en Sui... Nov 11, 2020 Guía para invertir en Suiza El manual contiene información sobre las ventajas clave de Suiza como ubicación para negocios, así como acerca del clima de investigación actual,...
News Dec 19, 2023 Top Stories from Western Switzerland (October-December 2023) From achieving top rankings in global innovation to making significant advancements in healthcare and technology, discover Western Switzerland's ...
Справочник инвестора Jul 28, 2021 Справочник инвестора В справочнике инвестора содержится информация по основным преимуществам Швейцарии как страны расположения бизнеса, а также по актуальному инвести...
Success stories May 25, 2023 Merck : “Switzerland offers attractive and stable conditions for international companies.“ Merck Science and technology leader Merck has been in Switzerland for almost a century. Today it has eight sites, including five manufacturing faciliti...
News Dec 11, 2023 Artbio and Scailyte making headlines in Basel The biotech company Scailyte has raised 8 million US dollars as part of a Series A financing round. For its part, Artbio has raised as much as 90...
瑞士投资指南 Jun 08, 2023 投资人手册 本手册介绍了瑞士作为现代化创新经济和技术驻地最重要的信息。 本手册囊括了例如经济体制、成立公司、税收、创新技术、劳动力市场和许可以及法律等方面的信息。